Revenue FY2025
$0.15B
Net Income
$(0.41B)
EPS (Basic)
$-11.11
Net Margin
-277.5%
ROE
-15.8%
Total Equity
$2.58B
Shares Out
45M
GRAIL, Inc. — Services-Medical Laboratories. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2023–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 1 fund in our universe
FundPosition Value% of AUMQoQ ChgWeight
Baker Bros. Advisors
Baker Bros. Advisors
$275.0M
1.0%
—
Insider Transactions
Reading stored insider transactions…